Leaders in Cardiovascular Research: A Special Issue Dedicated to Professor Patrick Serruys

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Cardiovascular Clinical Research".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 497

Special Issue Editors


E-Mail Website
Guest Editor
1. Barts Heart Centre, Barts Health NHS Trust, London E1 1BB, UK
2. Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London E1 4NS, UK
Interests: invasive and non-invasive coronary imaging; secondary prevention; computational fluid dynamics

E-Mail
Guest Editor
1. Department of Cardiology, Royal Blackburn Hospital, Blackburn BB2 3HH, UK
2. School of Medicine, University of Central Lancashire, Preston PR1 7BH, UK
Interests: coronary stents; risk stratification for coronary revascularization; myocardial revascularization

Special Issue Information

Dear Colleagues,

In 2019, The Journal of Cardiovascular Development and Disease (JCDD) began a series of Special Issues entitled “Leaders in Cardiovascular Research”, which aims to present the work of unique academics that have had a major impact in cardiovascular field and changed practise.

This Special Issue is dedicated to Professor Patrick Washington Serruys, an established researcher and academic who has shaped, and continues to shape, the field of interventional cardiology. For more than 50 years, Professor Serruys has been at the frontline of cardiovascular research. He played a pivotal role in the evolution of coronary stents and the advancement and adaptation of intravascular imaging technologies into routine clinical practise. He has contributed to the development and optimization of percutaneous therapies for valvular heart diseases and has conducted pivotal studies that have changed practise and improved outcomes in patients with coronary artery and valvular heart disease. In parallel, he has been a committed teacher who has supervised more than 100 PhD students, in this way, shaping future research in the field.

This commemorative Special Issue aims to include commissioned scientific papers and reviews on topics to which Professor Serruys has made substantial contributions. Academics that have similar research interests are welcome to contribute and are encouraged to contact the Guest Editors of this issue.

Prof. Dr. Christos V. Bourantas
Prof. Dr. Scot Garg
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary artery disease
  • intravascular imaging
  • percutaneous coronary interventions
  • transcatheter aortic valve implantation
  • coronary angiography
  • risk stratification
  • computed tomography coronary angiography
  • drug coated balloon

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 421 KiB  
Review
Drug-Coated Balloons: Recent Evidence and Upcoming Novelties
by Zaid Mohammad Fahmi Shahrori, Marco Frazzetto, Shamin Hayat Mahmud, Wasfi Alghwyeen and Bernardo Cortese
J. Cardiovasc. Dev. Dis. 2025, 12(5), 194; https://doi.org/10.3390/jcdd12050194 - 20 May 2025
Abstract
Drug-coated balloons (DCBs) have emerged as a compelling alternative to drug-eluting stents in the treatment of coronary artery disease (CAD), offering the advantage of local drug delivery without permanent vascular scaffold implantation. Initially developed for managing in-stent restenosis, DCBs seem appealing for broader [...] Read more.
Drug-coated balloons (DCBs) have emerged as a compelling alternative to drug-eluting stents in the treatment of coronary artery disease (CAD), offering the advantage of local drug delivery without permanent vascular scaffold implantation. Initially developed for managing in-stent restenosis, DCBs seem appealing for broader indications, particularly in small vessel disease and bifurcation lesions. While paclitaxel-based DCBs remain the most investigated, newer limus formulations are showing promise and appear to be a valid alternative in early trials. Evidence from recent randomized clinical trials (RCTs) and meta-analyses highlights DCBs as a safe and effective option in selected patients, with potential benefits including lower restenosis rates, reduced need for dual antiplatelet therapy, and avoidance of late stent-related complications. As new large-scale trials near completion, DCBs are poised to take on a broader role in the treatment of CAD, particularly in patients where “leaving nothing behind” offers a clinical advantage. This review offers an overview of the DCB platforms commercially available, showing pharmacological differences, providing current indications in practical guidelines, and analyzing the most recent and impactful RCTs and meta-analyses in the field. Full article
Show Figures

Figure 1

Back to TopTop